Update on colchicine, 2017.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29272515.
- Also identified by DOI 10.1093/rheumatology/kex453 and PMC identifier 5850858.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Colchicine is an ancient medication that is currently approved for the treatment of gout and FMF. However, colchicine has a wide range of anti-inflammatory activities, and studies indicate that it may be beneficial in a variety of other conditions. This paper reviews the evidence for the well-established use of colchicine in gout, as well as several other rheumatic diseases. In addition, we highlight the potential benefit of colchicine in cardiac disease, including coronary artery disease in patients both with and without gout.
Medical subject headings
- Cardiovascular Diseases
- Colchicine
- Gout